
[From gene to cell: Functional validation of RYR1 variants].
Genetic screening aids in diagnosing rare diseases. RYR1 variants often remain uncertain. AI and structural biology may improve classification. π§¬π
Discover the newest research about AI innovations in 𧬠Genetics.

Genetic screening aids in diagnosing rare diseases. RYR1 variants often remain uncertain. AI and structural biology may improve classification. π§¬π

Discover how VirtuDockDL enhances drug discovery using deep learning. 𧬠It achieves remarkable accuracy in identifying potential drug candidates. π

AI models assess physiological age using biomarkers, impacting drug metabolism. Key predictors include glycohemoglobin and systolic blood pressure. π§¬π

Recent research highlights lipid metabolism-related genes’ role in Alzheimer’s disease. Machine learning identifies potential biomarkers and treatment avenues. π§ π¬

AI transforms precision healthcare, enhancing patient outcomes and operational efficiency through genomic analysis and personalized wellness programs. π§¬π€

A significant collaboration between VA and DOE aims to enhance health outcomes through advanced data science and genomic analysis. π»π¬

Nanomaterials enhance biosensors for diagnostics, improving sensitivity and versatility in healthcare. Key advancements and challenges discussed. π§¬π¬

New AI tool PIONEER predicts protein interactions, aiding drug development for over 10,500 diseases. π§¬π

Government allocates Β£1.5 billion to tackle NHS waiting lists, aiming for two million extra appointments annually. π₯π°

Deep learning enhances cancer prediction using gene expression data. π€π WT-GAN improves data accuracy for better diagnosis. π©Ί